"Testicular Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the TESTIS. Germ cell tumors (GERMINOMA) of the testis constitute 95% of all testicular neoplasms.
Descriptor ID |
D013736
|
MeSH Number(s) |
C04.588.322.762 C04.588.945.440.915 C12.294.260.937 C12.758.409.937 C19.344.762 C19.391.829.782
|
Concept/Terms |
Testicular Neoplasms- Testicular Neoplasms
- Neoplasm, Testicular
- Testicular Neoplasm
- Testicular Tumors
- Testis Neoplasms
- Neoplasms, Testicular
- Neoplasms, Testis
- Neoplasm, Testis
- Testis Neoplasm
Tumor of Rete Testis- Tumor of Rete Testis
- Rete Testis Tumor
- Rete Testis Tumors
- Testis Tumor, Rete
- Testis Tumors, Rete
Cancer of Testis- Cancer of Testis
- Testis Cancers
- Testis Cancer
- Cancer, Testis
- Cancers, Testis
- Cancer of the Testes
- Cancer of the Testis
- Testicular Cancer
- Cancer, Testicular
- Cancers, Testicular
- Testicular Cancers
|
Below are MeSH descriptors whose meaning is more general than "Testicular Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Testicular Neoplasms".
This graph shows the total number of publications written about "Testicular Neoplasms" by people in this website by year, and whether "Testicular Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2005 | 1 | 0 | 1 |
2007 | 1 | 0 | 1 |
2008 | 1 | 0 | 1 |
2011 | 1 | 0 | 1 |
2016 | 1 | 0 | 1 |
2017 | 13 | 1 | 14 |
2018 | 10 | 0 | 10 |
2019 | 8 | 0 | 8 |
To return to the timeline, click here.
Below are the most recent publications written about "Testicular Neoplasms" by people in Profiles.
-
Movember in a pandemic - it matters, more than ever. Arch Ital Urol Androl. 2021 Mar 19; 93(1):82-83.
-
Four Cycles of Etoposide plus Cisplatin for Patients with Good-Risk Advanced Germ Cell Tumors. Oncologist. 2021 06; 26(6):483-491.
-
A narrative review of the history and evidence-base for the timing of orchidopexy for cryptorchidism. J Pediatr Urol. 2021 04; 17(2):239-245.
-
Management of urologic cancers during the pandemic and potential impact of treatment deferrals on outcomes. Urol Oncol. 2021 05; 39(5):258-267.
-
'Case of the Month' from Memorial Sloan Kettering Cancer Center, New York, NY, USA: managing newly diagnosed metastatic testicular germ cell tumour in a COVID-19-positive patient. BJU Int. 2020 09; 126(3):333-335.
-
Priorities in testis cancer care during Covid-19 Pandemic. Int Braz J Urol. 2020 07; 46(suppl.1):79-85.
-
[De-escalation: Testicular cancer.] Arch Esp Urol. 2020 Jun; 73(5):390-394.
-
Uro-oncology in times of COVID-19: The available evidence and recommendations in the Indian scenario. Indian J Cancer. 2020 Apr-Jun; 57(2):129-138.
-
Contemporary North-American population-based validation of the International Germ Cell Consensus Classification for metastatic germ cell tumors of the testis. World J Urol. 2020 Jun; 38(6):1535-1544.
-
Clinical presentation, management and follow-up of 83 patients with Leydig cell tumors of the testis: a prospective case-cohort study. Hum Reprod. 2019 08 01; 34(8):1389-1403.